Aterian, Inc. (NASDAQ:ATER – Get Free Report) saw a significant decline in short interest in the month of May. As of May 15th, there was short interest totaling 465,657 shares, a decline of 76.0% from the April 30th total of 1,939,342 shares. Currently, 5.3% of the shares of the company are short sold. Based on an average daily volume of 923,391 shares, the days-to-cover ratio is currently 0.5 days.
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently made changes to their positions in the company. XTX Topco Ltd acquired a new stake in shares of Aterian during the second quarter valued at $55,000. Susquehanna International Group LLP lifted its stake in shares of Aterian by 310.2% during the third quarter. Susquehanna International Group LLP now owns 40,512 shares of the company’s stock valued at $43,000 after buying an additional 30,637 shares during the period. Citadel Advisors LLC increased its stake in Aterian by 222.0% in the third quarter. Citadel Advisors LLC now owns 33,165 shares of the company’s stock valued at $35,000 after purchasing an additional 22,865 shares during the last quarter. Finally, Goldman Sachs Group Inc. increased its stake in Aterian by 73.0% in the first quarter. Goldman Sachs Group Inc. now owns 21,392 shares of the company’s stock valued at $45,000 after purchasing an additional 9,026 shares during the last quarter. Institutional investors and hedge funds own 7.02% of the company’s stock.
Analyst Upgrades and Downgrades
Separately, Weiss Ratings upgraded Aterian from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Tuesday, May 19th. One research analyst has rated the stock with a Sell rating, According to MarketBeat, the company currently has a consensus rating of “Sell”.
Aterian Price Performance
Shares of ATER stock traded down $0.04 during trading hours on Friday, reaching $1.12. 65,458 shares of the company’s stock were exchanged, compared to its average volume of 2,811,804. The company has a market cap of $12.06 million, a P/E ratio of -0.43 and a beta of 0.66. The company’s 50 day moving average is $0.86 and its two-hundred day moving average is $0.76. Aterian has a 1 year low of $0.52 and a 1 year high of $1.87.
Aterian (NASDAQ:ATER – Get Free Report) last issued its earnings results on Friday, May 15th. The company reported ($0.39) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.69) by $0.30. The business had revenue of $0.02 million during the quarter, compared to the consensus estimate of $15.82 million. Aterian had a negative return on equity of 82.05% and a negative net margin of 39.56%.
About Aterian
Aterian Inc is a technology-driven consumer products company that leverages artificial intelligence and machine learning to develop, source and market branded household, health and personal care products. Through its proprietary data analytics platform, Aterian identifies emerging trends, forecasts demand and optimizes product selection, pricing and distribution. The company maintains a vertically integrated supply chain, overseeing manufacturing partnerships and logistics to support rapid product development and market entry.
Aterian’s portfolio spans a range of categories including home and kitchen, health and wellness, baby care, beauty tools and electronics accessories.
Further Reading
- Five stocks we like better than Aterian
- Salesforce Stock Finds Support as AI Momentum Builds
- Dollar Tree Keeps Winning After Family Dollar Divorce
- Apple’s Agentic AI Plans Could Be Its Biggest Growth Story Yet
- Palomar’s High-Risk Insurance Strategy Is Paying Off Big
Receive News & Ratings for Aterian Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aterian and related companies with MarketBeat.com's FREE daily email newsletter.
